Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Probi

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types
Press release7/22/2025, 1:00 PM

Women's Health by Probi wins NutraIngredients-USA Award for Innovation in Women's Health

Probi
Press release5/28/2025, 6:37 AM

Probi Female wins prestigious NutraIngredients Award 2025 for innovation in women's health

Probi
Press release5/7/2025, 12:30 AM

First-of-its-kind: Nomura Dairy and Probi[ ]introduce probiotic-enhanced carrot juice to Japan

Probi

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/3/2025, 8:20 AM

Delisting of Probi

Probi
Regulatory press release1/20/2025, 9:01 PM

Notice of Extraordinary General Meeting in Probi AB (publ)

Probi
Regulatory press release1/20/2025, 9:00 PM

Probi applies for delisting and convenes an Extraordinary General Meeting

Probi
Regulatory press release1/9/2025, 7:00 AM

Probi postpones year-end report 2024

Probi
Regulatory press release12/13/2024, 4:17 PM

Statement from the independent bid committee of Probi in relation to the public takeover offer by Symrise

Probi
Regulatory press release11/20/2024, 6:19 AM

Probi's Board comments on Symrise's public takeover offer

Probi
Regulatory press release11/13/2024, 10:00 AM

Probi CFO departure

Probi
Press release10/23/2024, 11:00 AM

Probi Launches Clinically-Supported Probiotic Solution for Metabolic Health at SupplySide West 2024

Probi
Third party research10/23/2024, 5:24 AM

Probi: Managing costs well in Q3 - ABG

Miss on Q3 sales (-12%) and EBITDA (-10%) vs ABGSCe China faced headwinds due to macroeconomic factors EBITDA revised down by 2-3% for '24e-'26e Encouraging B2C sales efforts in the Nordics Probi reported a soft Q3'24 with sales amounting to SEK 143....

Probi
Probi, Audiocast with teleconference, Q3'24
Webcast10/22/2024, 8:00 AM

Probi, Audiocast with teleconference, Q3'24

Probi
Regulatory press release10/22/2024, 6:00 AM

Probi: Q3 2024: Tangible improvement in operations

Probi
Press release10/17/2024, 6:50 AM

Presentation of Probi's Q3 Report 2024

Probi
Press release10/16/2024, 11:30 AM

Probi partners with Global BHP BrainTrust and the FINGERS Brain Health Institute to counteract dementia

Probi
Press release10/10/2024, 7:00 AM

Nordic launch of Probi Sense - a unique dietary supplement for the mental capacity

Probi
Press release9/24/2024, 11:00 AM

New study strengthens Probi[ ][®]s L. plantarum HEAL9[®] strain in cognitive function

Probi
Third party research7/17/2024, 6:29 AM

Probi: FY'24e marks a transition to a promising future - ABG

- Beat on Q2 sales (+3%) and EBITDA (+24%) vs ABGSCe - EBITDA up 2% for '24e and 1% for '25e - Our comprehensive analysis indicates a promising long-term outlook Americas and EMEA progressed well in Q2 Probi reported a strong Q2'24 driven by growth in...

Probi
Probi, Audiocast with teleconference, Q2'24
Webcast7/16/2024, 8:00 AM

Probi, Audiocast with teleconference, Q2'24

Probi
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.